Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...
Guardado en:
| Autor principal: | Xiangjun Wang (2522917) (author) |
|---|---|
| Otros Autores: | Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author) |
| Publicado: |
2025
|
| Materias: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
por: Xiangjun Wang (2522917)
Publicado: (2025) -
Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
por: Xiangjun Wang (2522917)
Publicado: (2025) -
Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
por: Xiangjun Wang (2522917)
Publicado: (2025) -
Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
por: Xiangjun Wang (2522917)
Publicado: (2025) -
Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
por: Xiangjun Wang (2522917)
Publicado: (2025)